MAPT and Alzheimer disease: Detection of intracellular tau protein extracellularly in interstitial space or CSF in AD patients [41, 97–99] and controversy in studies examining intracellular [13, 33, 81] vs extracellular mode of action of antibodies, shifted most of the current research to screen for antibodies targeting predominantly extracellular tau species [36].